| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 161 | 340 | 1,090 | $70 | $1.4M |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 42 | 100 | 1,490 | $70 | $1.3M |
| G0378 | Hospital observation service, per hour | 36 | 130 | 1,270 | $560 | $1.2M |
| 96361 | The provider administers intravenous, or IV, fluids with electrolytes through an already established intravenous route for each additional hour to treat more severe dehydration. | 74 | 210 | 2,850 | $180 | $1.1M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 31 | 180 | 3,200 | $90 | $1M |
| 90834 | In this service, the provider performs psychotherapy, a series of techniques for treating the psychiatric disorders of the patient. The treatment session with the patient typically lasts for anywhere… | 1,646 | 2,200 | 1,010 | $130 | $892.2K |
| 99283 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a low level of medical decision making. | 209 | 1,420 | 90 | $130 | $715.2K |
| 99282 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a straightforward level of medical decision making. | 100 | 450 | 370 | $170 | $674.1K |
| Q9992 | Injection, buprenorphine extended-release (sublocade), greater than 100 mg | 8 | 10 | 260 | $1,320 | $503.5K |
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 154 | 2,210 | 80 | $130 | $473K |